DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
Clinical trial NCT03361098 · COMPLETED
Trial details
- NCT number
- NCT03361098
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2019-11-25
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.